Title: Establishment of a novel mouse model for pioglitazone-induced skeletal muscle injury.
Journal: Toxicology 20170501
Title: Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.
Journal: Journal of pharmaceutical sciences 20150901
Title: Synthesis of kifunensine thioanalogs and their inhibitory activities against HIV-RT and α-mannosidase.
Journal: Carbohydrate research 20130110
Title: Density functional study on the cytochrome-mediated S-oxidation: identification of crucial reactive intermediate on the metabolic path of thiazolidinediones.
Journal: The journal of physical chemistry. A 20121025
Title: Adiponectin and all-cause mortality in elderly people with type 2 diabetes.
Journal: Diabetes care 20120901
Title: Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
Journal: European journal of medicinal chemistry 20120701
Title: Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Journal: Canadian journal of physiology and pharmacology 20120701
Title: Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.
Journal: British journal of pharmacology 20120601
Title: 5-benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials.
Journal: Bioorganic & medicinal chemistry letters 20120415
Title: Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c.
Journal: Primary care diabetes 20120401
Title: Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
Journal: Endocrinology 20120301
Title: Effect of structural modifications on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats.
Journal: Journal of applied toxicology : JAT 20120201
Title: Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity.
Journal: Chemistry & biology 20120127
Title: Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry.
Journal: Journal of medicinal chemistry 20120126
Title: PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease.
Journal: Neurobiology of disease 20120101
Title: Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties.
Journal: Bioorganic & medicinal chemistry letters 20120101
Title: In vivo adipogenesis in rats measured by cell kinetics in adipocytes and plastic-adherent stroma-vascular cells in response to high-fat diet and thiazolidinedione.
Journal: Diabetes 20120101
Title: New cholesterol esterase inhibitors based on rhodanine and thiazolidinedione scaffolds.
Journal: Bioorganic & medicinal chemistry 20111215
Title: The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
Journal: Endocrine, metabolic & immune disorders drug targets 20111201
Title: Comparison of the acute toxicities of novel algicides, thiazolidinedione derivatives TD49 and TD53, to various marine organisms.
Journal: Environmental toxicology and chemistry 20111201
Title: Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes.
Journal: Pharmacogenetics and genomics 20111201
Title: Effects of plane of nutrition and 2,4-thiazolidinedione on insulin responses and adipose tissue gene expression in dairy cattle during late gestation.
Journal: Journal of dairy science 20111201
Title: Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-α and leptin, and adipose tissue gene expression.
Journal: Journal of dairy science 20111101
Title: Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation.
Journal: Nature 20110922
Title: The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease.
Journal: Biochimica et biophysica acta 20110901
Title: Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B.
Journal: Bioorganic & medicinal chemistry letters 20110815
Title: Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Journal: Circulation 20110809
Title: Synthesis of new chalcone derivatives bearing 2,4-thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents.
Journal: European journal of medicinal chemistry 20110801
Title: High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.
Journal: Chemistry & biology 20110729
Title: Efficacy and safety of saxagliptin combination therapy in US patients with type 2 diabetes.
Journal: Postgraduate medicine 20110701
Title: Synthesis of spirocyclic thiazolidinediones using ring-closing metathesis and one-pot sequential ring-closing/cross metathesis.
Journal: Organic & biomolecular chemistry 20110521
Title: Peroxisome proliferator-activated receptor-γ stimulates 11β-hydroxysteroid dehydrogenase type 1 in rat vascular smooth muscle cells.
Journal: Steroids 20110501
Title: Changes and predictors for change to thiazolidinedione prescribing in UK primary care following the rosiglitazone safety warning.
Journal: International journal of clinical practice 20110501
Title: [Effects of drugs for lifestyle-related diseases on bone metabolism].
Journal: Clinical calcium 20110501
Title: [Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Journal: Clinical calcium 20110501
Title: Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.
Journal: Journal of medicinal chemistry 20110414
Title: Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data.
Journal: Inflammatory bowel diseases 20110301
Title: Interaction of phytochemicals with hypoglycemic drugs on glucose uptake in L6 myotubes.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20110215
Title: S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and C4a-hydroperoxyflavin: a theoretical study.
Journal: The journal of physical chemistry. A 20110210
Title: Convenient synthesis of polyfunctional dihydrothiophenes with tandem reaction of 1,3-thiazolidinedione, aldehyde, arylamine and ethyl cyanoacetate.
Journal: Molecular diversity 20110201
Title: Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20110201
Title: An arylidene-thiazolidinedione derivative, GPU-4, without PPARγ activation, reduces retinal neovascularization.
Journal: Current neurovascular research 20110201
Title: Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101
Title: Thiazolidinedione therapy for managing metabolic syndrome.
Journal: American family physician 20101215
Title: Thiazolidinediones as a novel class of algicides against red tide harmful algal species.
Journal: Applied biochemistry and biotechnology 20101201
Title: Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: a retrospective analysis of the GALIANT study.
Journal: Diabetes research and clinical practice 20101101
Title: Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma.
Journal: Human molecular genetics 20101015
Title: Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.
Journal: Diabetes care 20101001
Title: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Journal: Diabetes care 20101001
Title: Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives.
Journal: European journal of medicinal chemistry 20101001
Title: Effects of in vitro insulin and 2,4-thiazolidinedione on the function of neutrophils harvested from blood of cows in different physiological states.
Journal: Journal of dairy science 20100901
Title: Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis.
Journal: The Journal of biological chemistry 20100827
Title: Modulation of pantothenate kinase 3 activity by small molecules that interact with the substrate/allosteric regulatory domain.
Journal: Chemistry & biology 20100827
Title: MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Journal: European journal of pharmacology 20100710
Title: Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes.
Journal: Diabetes research and clinical practice 20100701
Title: Bone loss and fracture risk associated with thiazolidinedione therapy.
Journal: Pharmacotherapy 20100701
Title: A perspective on the American Heart Association/American College of Cardiology science advisory on thiazolidinedione drugs and cardiovascular risks.
Journal: Circulation. Cardiovascular quality and outcomes 20100501
Title: [Revascularization in patients with type 2 diabetes and coronary artery disease: BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group].
Journal: Der Internist 20100501
Title: Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea.
Journal: The Annals of pharmacotherapy 20100501
Title: Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents.
Journal: Bioorganic & medicinal chemistry 20100301
Title: Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy.
Journal: Archives of ophthalmology (Chicago, Ill. : 1960) 20100301
Title: Binding of histidine in the (Cys)3(His)1-coordinated [2Fe-2S] cluster of human mitoNEET.
Journal: Journal of the American Chemical Society 20100217
Title: Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
Journal: Toxicology letters 20100201
Title: Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists.
Journal: Bioorganic & medicinal chemistry letters 20100201
Title: Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET.
Journal: Bioorganic & medicinal chemistry letters 20100201
Title: Thiazolidinedione therapy for nonalcoholic steatohepatitis: go, stop, or proceed with caution?
Journal: Hepatology (Baltimore, Md.) 20100201
Title: Thiazolidinedione attenuate proteinuria and glomerulosclerosis in Adriamycin-induced nephropathy rats via slit diaphragm protection.
Journal: Nephrology (Carlton, Vic.) 20100201
Title: Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Journal: Postgraduate medicine 20100101
Title: Biguanide, but not thiazolidinedione, improved insulin resistance in Werner syndrome.
Journal: Journal of the American Geriatrics Society 20100101
Title: Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes.
Journal: Cardiology in review 20100101
Title: Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice.
Journal: PloS one 20100101
Title: Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology 20091201
Title: Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
Journal: Hepatology (Baltimore, Md.) 20091001
Title: Synthesis and in vitro anticancer activity of 2,4-azolidinedione-acetic acids derivatives.
Journal: European journal of medicinal chemistry 20090901
Title: A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial.
Journal: Diabetes technology & therapeutics 20090901
Title: CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors.
Journal: Journal of molecular modeling 20090701
Title: A randomized trial of therapies for type 2 diabetes and coronary artery disease.
Journal: The New England journal of medicine 20090611
Title: Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090515
Title: Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones.
Journal: European journal of medicinal chemistry 20090501
Title: Synthesis of novel thiourea, thiazolidinedione and thioparabanic acid derivatives of 4-aminoquinoline as potent antimalarials.
Journal: Bioorganic & medicinal chemistry letters 20090501
Title: Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Journal: Diabetes, obesity & metabolism 20090501
Title: Thiazolidinedione use and the risk of fractures.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090414
Title: Thiazolidinedione use and the risk of fractures.
Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090414
Title: Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity.
Journal: Journal of the American Society of Nephrology : JASN 20090401
Title: Quantitative structure-activity relationship models with receptor-dependent descriptors for predicting peroxisome proliferator-activated receptor activities of thiazolidinedione and oxazolidinedione derivatives.
Journal: Chemical biology & drug design 20090401
Title: Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.
Journal: Journal of medicinal chemistry 20090108
Title: Impact of peripheral arterial disease in patients with diabetes--results from PROactive (PROactive 11).
Journal: Atherosclerosis 20090101
Title: Factors associated with results and conclusions of trials of thiazolidinediones.
Journal: PloS one 20090101
Title: Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus.
Journal: Gastroenterology 20081201
Title: Thiazolidinedione associated volume overload and pulmonary hypertension.
Journal: Therapeutic advances in cardiovascular disease 20081201
Title: Synthesis and aldose reductase inhibitory activity of some new chromonyl-2,4-thiazolidinediones.
Journal: European journal of medicinal chemistry 20081101
Title: An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients.
Journal: Pharmacoepidemiology and drug safety 20081001
Title: Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.
Journal: Diabetes, obesity & metabolism 20080601
Title: Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study.
Journal: Diabetes, obesity & metabolism 20080601
Title: Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.
Journal: Bioorganic & medicinal chemistry 20080601
Title: Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.
Journal: Translational research : the journal of laboratory and clinical medicine 20080601
Title: [Do thiazolidinediones harm skeletal integrity?].
Journal: Clinical calcium 20080501
Title: [Relationship between lipid and glucose metabolism and bone mineral metabolism : pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia].
Journal: Clinical calcium 20080501
Title: Differing pharmacological activities of thiazolidinone analogs at the FSH receptor.
Journal: Biochemical and biophysical research communications 20080411
Title: T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
Journal: The Journal of biological chemistry 20080404
Title: Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20080401
Title: Electrophilic alpha-thiocyanation of chiral and achiral N-acyl imides. A convenient route to 5-substituted and 5,5-disubstituted 2,4-thiazolidinediones.
Journal: Bioorganic & medicinal chemistry letters 20080315
Title: Sitagliptin: a novel agent for the management of type 2 diabetes mellitus.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080315
Title: Antiproteinuric and anti-inflammatory effects of thiazolidinedione.
Journal: Nephrology (Carlton, Vic.) 20080201
Title: Oral antidiabetic medication adherence and glycemic control in managed care.
Journal: The American journal of managed care 20080201
Title: Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
Journal: Diabetes, obesity & metabolism 20080101
Title: Fat and beyond: the diverse biology of PPARgamma.
Journal: Annual review of biochemistry 20080101
Title: Statins but not thiazolidinediones attenuate albumin-mediated chemokine production by proximal tubular cells independently of endocytosis.
Journal: American journal of nephrology 20080101
Title: Performing meta-analysis with incomplete statistical information in clinical trials.
Journal: BMC medical research methodology 20080101
Title: Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.
Journal: Health and quality of life outcomes 20080101
Title: Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study.
Journal: Current medical research and opinion 20071101
Title: Adipose tissue integrity as a prerequisite for systemic energy balance: a critical role for peroxisome proliferator-activated receptor gamma.
Journal: The Journal of biological chemistry 20071012
Title: Synthesis and three-dimensional qualitative structure selectivity relationship of 3,5-disubstituted-2,4-thiazolidinedione derivatives as COX2 inhibitors.
Journal: Archives of pharmacal research 20071001
Title: Cytosolic aspartate aminotransferase, a new partner in adipocyte glyceroneogenesis and an atypical target of thiazolidinedione.
Journal: The Journal of biological chemistry 20070810
Title: Prepartum 2,4-thiazolidinedione alters metabolic dynamics and dry matter intake of dairy cows.
Journal: Journal of dairy science 20070801
Title: Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
Journal: The American journal of managed care 20070801
Title: Pharmacogenetics of thiazolidinedione therapy.
Journal: Pharmacogenomics 20070801
Title: Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Journal: The Journal of biological chemistry 20070706
Title: The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure.
Journal: Journal of the American College of Cardiology 20070703
Title: Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials.
Journal: American heart journal 20070701
Title: Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Journal: Molecular pharmacology 20070601
Title: Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Journal: Diabetes care 20070601
Title: Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Journal: Molecular pharmacology 20070601
Title: Thiazolidinedione therapy gets complicated: is bone loss the price of improved insulin resistance?
Journal: Diabetes care 20070601
Title: Inhaled insulin for diabetes mellitus.
Journal: The New England journal of medicine 20070517
Title: Novel thyroid hormone receptor antagonists with an N-alkylated diphenylamine skeleton.
Journal: Bioorganic & medicinal chemistry 20070501
Title: Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway.
Journal: The Journal of biological chemistry 20070406
Title: Summaries for patients. Exenatide therapy for type 2 diabetes.
Journal: Annals of internal medicine 20070403
Title: The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Journal: Annals of internal medicine 20070403
Title: Exenatide in combination therapy: small study, big market, and many unanswered questions.
Journal: Annals of internal medicine 20070403
Title: Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
Journal: American journal of physiology. Renal physiology 20070401
Title: Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study.
Journal: Diabetes, obesity & metabolism 20070301
Title: Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
Journal: Nature medicine 20070301
Title: Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation.
Journal: The Journal of clinical endocrinology and metabolism 20070201
Title: The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance.
Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire 20070201
Title: Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor.
Journal: Japanese journal of ophthalmology 20070101
Title: Thiazolidinedione induced thyroid associated orbitopathy.
Journal: BMC ophthalmology 20070101
Title: The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment.
Journal: Journal of lipid research 20061101
Title: Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Journal: Bone 20061001
Title: Thiazolidinedione use and bone loss in older diabetic adults.
Journal: The Journal of clinical endocrinology and metabolism 20060901
Title: Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione.
Journal: Diabetologia 20060901
Title: Endothelial dysfunction and its role in diabetic vascular disease.
Journal: Endocrinology and metabolism clinics of North America 20060901
Title: Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060801
Title: Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione.
Journal: Experimental gerontology 20060601
Title: Can thiazolidinediones delay disease progression in type 2 diabetes?
Journal: Current medical research and opinion 20060601
Title: Etiology of insulin resistance.
Journal: The American journal of medicine 20060501
Title: Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus.
Journal: The American journal of cardiology 20060301
Title: Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis.
Journal: Current medical research and opinion 20060301
Title: Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20060201
Title: Attenuation of experimental colonic injury by thiazolidinedione agents.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20060101
Title: Treatment of type 2 diabetes. Use of fixed-dose oral combinations.
Journal: Postgraduate medicine 20060101
Title: Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ring.
Journal: Arzneimittel-Forschung 20060101
Title: Oral agents in managing diabetes mellitus in children and adolescents.
Journal: Pediatric clinics of North America 20051201
Title: SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.
Journal: Journal of medicinal chemistry 20051117
Title: [Insulin resistance: the adipose tissue in the focus].
Journal: Orvosi hetilap 20051023
Title: [The effects of thiazolidinedione from the cardiologic viewpoint].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20051001
Title: Impact of thiazolidinedione therapy on atherogenesis.
Journal: Current atherosclerosis reports 20050901
Title: Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis.
Journal: World journal of gastroenterology 20050828
Title: Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Journal: Acta pharmacologica Sinica 20050601
Title: The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
Journal: The Journal of pharmacology and experimental therapeutics 20050501
Title: Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone.
Journal: The Journal of nutrition 20050501
Title: [Polycystic ovary syndrome].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050401
Title: Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.
Journal: Journal of cardiology 20050401
Title: Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
Journal: The Journal of biological chemistry 20050318
Title: PPAR-gamma activation fails to provide myocardial protection in ischemia and reperfusion in pigs.
Journal: American journal of physiology. Heart and circulatory physiology 20050301
Title: Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
Journal: The Journal of biological chemistry 20050225
Title: Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.
Journal: Genes & development 20050215
Title: [Selection of oral antidiabetic drugs].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050201
Title: The utility of oral diabetes medications in type 2 diabetes of the young.
Journal: Current diabetes reviews 20050201
Title: Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide.
Journal: The Journal of pharmacology and experimental therapeutics 20050101
Title: Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus.
Journal: Drugs 20050101
Title: Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients.
Journal: Diabetes, obesity & metabolism 20050101
Title: Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of type 2 diabetes.
Journal: Diabetologia 20041201
Title: Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability.
Journal: Diabetes technology & therapeutics 20041201
Title: Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes.
Journal: Bioinformatics (Oxford, England) 20041122
Title: Peroxisome proliferator-activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells.
Journal: Genes to cells : devoted to molecular & cellular mechanisms 20041101
Title: Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites.
Journal: Gastroenterology 20041101
Title: Synthesis and biological activity of benzoxazole containing thiazolidinedione derivatives.
Journal: Archives of pharmacal research 20041101
Title: Application of liquid chromatography/mass spectrometry and nuclear magnetic resonance to the identification of degradates of a novel insulin sensitizer in aqueous solutions.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041025
Title: Integrated genomic and proteomic analyses of gene expression in Mammalian cells.
Journal: Molecular & cellular proteomics : MCP 20041001
Title: Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.
Journal: Current medical research and opinion 20041001
Title: Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.
Journal: International journal of oncology 20040901
Title: Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.
Journal: Molecular cancer therapeutics 20040801
Title: Continuation of thiazolidinedione therapy in patients without left ventricular dysfunction who developed edema and congestive-heart-failure symptoms.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040801
Title: Limited tumor growth (HT29) in vivo under RO205-2349 is due to increased apoptosis and reduced cell volume but not to decreased proliferation rate.
Journal: Cancer letters 20040708
Title: Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells.
Journal: The Journal of nutrition 20040701
Title: Increased adipose tissue expression of Grb14 in several models of insulin resistance.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040601
Title: Quantitative determination of a novel insulin sensitizer and its para-hydroxylated metabolite in human plasma by LC-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20040528
Title: Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Journal: Cancer research 20040515
Title: Coronary vasomotor abnormalities in insulin-resistant individuals.
Journal: Annals of internal medicine 20040504
Title: Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity.
Journal: Endocrinology 20040501
Title: Thiazolidinedione-induced congestive heart failure.
Journal: The Annals of pharmacotherapy 20040501
Title: Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.
Journal: Diabetologia 20040501
Title: Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedione.
Journal: European journal of medicinal chemistry 20040501
Title: Cinnamic acid based thiazolidinediones inhibit human P450c17 and 3beta-hydroxysteroid dehydrogenase and improve insulin sensitivity independent of PPARgamma agonist activity.
Journal: Journal of molecular endocrinology 20040401
Title: [Achieving better control of blood sugar--understanding of oral hypoglycemic agents according to their characteristics in pharmacological action mechanism (discussion)].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040401
Title: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.
Journal: The Journal of biological chemistry 20040326
Title: Type 2 diabetes mellitus: what is the optimal treatment regimen?
Journal: The American journal of medicine 20040308
Title: Increased CD36 protein as a response to defective insulin signaling in macrophages.
Journal: The Journal of clinical investigation 20040301
Title: Prevalence of edema in patients receiving combination therapy with insulin and thiazolidinedione.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040215
Title: Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats.
Journal: Pediatric nephrology (Berlin, Germany) 20040101
Title: Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma.
Journal: International journal of oncology 20040101
Title: Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
Journal: Diabetes care 20040101
Title: Cardiovascular implications of thiazolidinedione therapy.
Journal: Progress in cardiovascular nursing 20040101
Title: Cbl PYXXM motifs activate the P85 subunit of phosphatidylinositol 3-kinase, Crk, atypical protein kinase C, and glucose transport during thiazolidinedione action in 3T3/L1 and human adipocytes.
Journal: Biochemistry 20031209
Title: The roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular disease.
Journal: The American journal of medicine 20031208
Title: Beta-cell rejuvenation with thiazolidinediones.
Journal: The American journal of medicine 20031208
Title: Free fatty acids and type 2 diabetes mellitus.
Journal: The American journal of medicine 20031208
Title: Hypertension and nephropathy.
Journal: The American journal of medicine 20031208
Title: The vascular biology of atherosclerosis.
Journal: The American journal of medicine 20031208
Title: Novel actions of thiazolidinediones on vascular function and exercise capacity.
Journal: The American journal of medicine 20031208
Title: Insulin resistance and the effects of thiazolidinediones on cardiac metabolism.
Journal: The American journal of medicine 20031208
Title: Vascular reactivity and thiazolidinediones.
Journal: The American journal of medicine 20031208
Title: Thiazolidinedione regulation of smooth muscle cell proliferation.
Journal: The American journal of medicine 20031208
Title: Considerations for management of fluid dynamic issues associated with thiazolidinediones.
Journal: The American journal of medicine 20031208
Title: Muscle-specific Pparg deletion causes insulin resistance.
Journal: Nature medicine 20031201
Title: Antiedematogenic activity of two thiazolidine derivatives: N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene) rhodanine (GS26) and N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2,4-thiazolidinedione (GS28).
Journal: Chemical & pharmaceutical bulletin 20031201
Title: [The effect of peroxisome proliferator-activated receptor alpha and gamma ligands on free fatty acid-induced INS-1 cell impairment].
Journal: Zhonghua nei ke za zhi 20031201
Title: Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes.
Journal: Biochimie 20031201
Title: Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
Journal: Biochimie 20031201
Title: Paradoxical lowering of high-density lipoprotein cholesterol level in 2 patients receiving fenofibrate and a thiazolidinedione.
Journal: Annals of internal medicine 20031104
Title: Zinc modulates PPARgamma signaling and activation of porcine endothelial cells.
Journal: The Journal of nutrition 20031001
Title: A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice.
Journal: Biochemical and biophysical research communications 20030919
Title: Adiponectin gene activation by thiazolidinediones requires PPAR gamma 2, but not C/EBP alpha-evidence for differential regulation of the aP2 and adiponectin genes.
Journal: Biochemical and biophysical research communications 20030905
Title: Thiazolidinedione-associated congestive heart failure and pulmonary edema.
Journal: Mayo Clinic proceedings 20030901
Title: Diabetes drugs a problem in heart failure.
Journal: Harvard heart letter : from Harvard Medical School 20030901
Title: Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism.
Journal: FEBS letters 20030828
Title: Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia.
Journal: The American journal of cardiology 20030818
Title: Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
Journal: The Journal of biological chemistry 20030815
Title: Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
Journal: The Journal of clinical investigation 20030815
Title: Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs).
Journal: Bioorganic & medicinal chemistry letters 20030804
Title: PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
Journal: The Journal of pharmacology and experimental therapeutics 20030801
Title: Peroxisome proliferator-activated receptors (PPARS): regulators of gene expression in heart and skeletal muscle.
Journal: Acta physiologica Scandinavica 20030801
Title: Benefits of combination therapy of insulin and oral hypoglycemic agents.
Journal: Archives of internal medicine 20030801
Title: Metformin and thiazolidinedione use in Medicare patients with heart failure.
Journal: JAMA 20030702
Title: [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030701
Title: New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione.
Journal: Clinical therapeutics 20030701
Title: The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.
Journal: The Journal of clinical endocrinology and metabolism 20030601
Title: 5-Aryl thiazolidine-2,4-diones as selective PPARgamma agonists.
Journal: Bioorganic & medicinal chemistry letters 20030519
Title: Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis.
Journal: Journal of cellular biochemistry 20030501
Title: PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.
Journal: The Journal of clinical investigation 20030501
Title: Identification of novel metabolites of pioglitazone in rat and dog.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20030501
Title: Lessons learned from landmark trials of type 2 diabetes mellitus and potential applications to clinical practice.
Journal: Postgraduate medicine 20030501
Title: Insulin resistance syndrome. Description, pathogenesis, and management.
Journal: Postgraduate medicine 20030501
Title: Constructing an algorithm for managing type 2 diabetes. Focus on role of the thiazolidinediones.
Journal: Postgraduate medicine 20030501
Title: A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Journal: European journal of pharmacology 20030418
Title: Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
Journal: Journal of the American College of Cardiology 20030416
Title: Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20030401
Title: Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs?
Journal: Expert opinion on investigational drugs 20030401
Title: Insulin sensitizers.
Journal: Mayo Clinic proceedings 20030401
Title: Resistin: molecular history and prognosis.
Journal: Journal of molecular medicine (Berlin, Germany) 20030401
Title: Synthesis and antihyperglycemic activity of erythrose, ribose and substituted pyrrolidine containing thiazolidinedione derivatives.
Journal: Chemical & pharmaceutical bulletin 20030301
Title: Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes.
Journal: The Journal of biological chemistry 20030221
Title: A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs.
Journal: Biochemical and biophysical research communications 20030207
Title: Studies on non-thiazolidinedione antidiabetic agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents.
Journal: Chemical & pharmaceutical bulletin 20030201
Title: PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
Journal: International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20030201
Title: Treatment of insulin resistance in uremia.
Journal: The International journal of artificial organs 20030201
Title: Activation of PPARgamma increases PTEN expression in pancreatic cancer cells.
Journal: Biochemical and biophysical research communications 20030131
Title: Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells.
Journal: Biochemical pharmacology 20030115
Title: Vanadyl-thiazolidinedione combination agents for diabetes therapy.
Journal: Bioconjugate chemistry 20030101
Title: Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives--fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones.
Journal: Farmaco (Societa chimica italiana : 1989) 20030101
Title: Continuing education.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20030101
Title: [Lipodystrophies: what treatment?].
Journal: Journees annuelles de diabetologie de l'Hotel-Dieu 20030101
Title: Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101
Title: Thiazolidinedione therapy: the benefits of aggressive and early use in type 2 diabetes.
Journal: Diabetes technology & therapeutics 20030101
Title: Pancreatic beta-cell loss and preservation in type 2 diabetes.
Journal: Clinical therapeutics 20030101
Title: Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101
Title: Therapy for type 2 diabetes.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101
Title: Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin.
Journal: FEBS letters 20021218
Title: 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
Journal: British journal of cancer 20021202
Title: Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver.
Journal: Endocrinology 20021201
Title: [Thiazolidinediones in type 2 diabetes. Role of peroxisome proliferator-activated receptor gamma (PPARgamma)].
Journal: Annales d'endocrinologie 20021201
Title: A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
Journal: Cleveland Clinic journal of medicine 20021201
Title: Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
Journal: Diabetes research and clinical practice 20021101
Title: Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.
Journal: Current cardiology reports 20021101
Title: Therapeutic options for the management of type 2 diabetes mellitus.
Journal: The American journal of managed care 20021101
Title: [Discovery and development of a new insulin sensitizing agent, pioglitazone].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20021101
Title: Oral anti diabetic polychemotherapy in type 2 diabetes mellitus.
Journal: Diabetes & metabolism 20021101
Title: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Journal: Diabetes 20021001
Title: Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR spectroscopy.
Journal: Magnetic resonance in medicine 20021001
Title: Seeking sweet relief for diabetes.
Journal: Nature biotechnology 20021001
Title: A futile metabolic cycle activated in adipocytes by antidiabetic agents.
Journal: Nature medicine 20021001
Title: PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
Journal: The Journal of clinical investigation 20021001
Title: Studies on non-thiazolidinedione antidiabetic agents. 1. Discovery of novel oxyiminoacetic acid derivatives.
Journal: Chemical & pharmaceutical bulletin 20021001
Title: Effects of thiazolidinediones for early treatment of type 2 diabetes mellitus.
Journal: The American journal of managed care 20021001
Title: Thiazolidinediones in the treatment of managed care patients with type 2 diabetes.
Journal: The American journal of managed care 20021001
Title: [Combination therapy with biguanides].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021001
Title: Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
Journal: Methods and findings in experimental and clinical pharmacology 20021001
Title: Thiazolidinediones increase the number of platelets in immune thrombocytopenic purpura mice via inhibition of phagocytic activity of the reticulo-endothelial system.
Journal: Life sciences 20020913
Title: PMT13, a pyrimidone analogue of thiazolidinedione improves insulin resistance-associated disorders in animal models of type 2 diabetes.
Journal: Diabetes, obesity & metabolism 20020901
Title: Combination therapy with nateglinide and a thiazolidinedione improves glycemic control in type 2 diabetes.
Journal: Diabetes care 20020901
Title: Thiazolidinediones: metabolic actions in vitro.
Journal: Diabetologia 20020901
Title: [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: [Glitazone--a new drug for type 2 diabetes].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: [Chemical structures and pharmacological characteristics of novel non-thiazolidinedione insulin sensitizer (JTT-501, FK614)].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival.
Journal: The Journal of biological chemistry 20020830
Title: Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives.
Journal: Bioorganic & medicinal chemistry 20020801
Title: Possible vascular-protective effects of antidiabetic agents such as the thiazolidinediones (TZDs).
Journal: Clinical therapeutics 20020801
Title: Biology and toxicology of PPARgamma ligands.
Journal: Human & experimental toxicology 20020801
Title: Endothelium, inflammation, and diabetes.
Journal: Current diabetes reports 20020801
Title: The gene encoding the Acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor gamma through an intronic response element functionally conserved between humans and rodents.
Journal: The Journal of biological chemistry 20020726
Title: Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3.
Journal: International journal of oncology 20020701
Title: Impaired ('diabetic') insulin signaling and action occur in fat cells long before glucose intolerance--is insulin resistance initiated in the adipose tissue?
Journal: International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20020701
Title: Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
Journal: Diabetes 20020701
Title: Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20020701
Title: Peroxisome proliferator-activated receptor-gamma expression in lung.
Journal: Chest 20020701
Title: Thiazolidinedione-induced edema.
Journal: Pharmacotherapy 20020701
Title: Understanding insulin-resistance in type 2 diabetes.
Journal: Journal of the National Medical Association 20020701
Title: Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose).
Journal: The American journal of cardiology 20020601
Title: Genetics and molecular biology: peroxisome proliferator-activated receptor gamma still full of surprises.
Journal: Current opinion in lipidology 20020601
Title: The glitazones: a new treatment for type 2 diabetes mellitus.
Journal: Intensive & critical care nursing 20020601
Title: Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.
Journal: The Journal of biological chemistry 20020510
Title: Thiazolidinediones in the treatment of type 2 diabetes.
Journal: Expert opinion on pharmacotherapy 20020501
Title: Clinical inquiries. How beneficial are thiazolidinediones for diabetes mellitus?
Journal: The Journal of family practice 20020501
Title: Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.
Journal: Bioorganic & medicinal chemistry 20020401
Title: Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.
Journal: Diabetes 20020401
Title: 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death.
Journal: Kidney international 20020401
Title: Polycystic ovary syndrome. Long term sequelae and management.
Journal: Minerva ginecologica 20020401
Title: [PPARgamma and insulin resistance].
Journal: Annales d'endocrinologie 20020401
Title: [Glitazones and weight gain].
Journal: Annales d'endocrinologie 20020401
Title: [Precautions for use and contraindications of thiazolidinediones. A cardiologist opinion].
Journal: Annales d'endocrinologie 20020401
Title: [Is a new therapeutic class justified in the treatment of type 2 diabetes?].
Journal: Annales d'endocrinologie 20020401
Title: Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities.
Journal: Journal of medicinal chemistry 20020328
Title: Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
Journal: Oncogene 20020328
Title: Thiazolidinedione derivatives as novel therapeutic agents to prevent the development of chronic pancreatitis.
Journal: Pancreas 20020301
Title: Regional differences in the response of human pre-adipocytes to PPARgamma and RXRalpha agonists.
Journal: Diabetes 20020301
Title: Type 2 diabetes therapy. A pathophysiologically based approach.
Journal: Postgraduate medicine 20020301
Title: Toxicological consequences of altered peroxisome proliferator-activated receptor gamma (PPARgamma) expression in the liver: insights from models of obesity and type 2 diabetes.
Journal: Biochemical pharmacology 20020101
Title: Treatment of type 2 diabetes mellitus: pharmacologic intervention.
Journal: The Journal of cardiovascular nursing 20020101
Title: Diabetes mellitus. Medication update.
Journal: Southern medical journal 20020101
Title: A treatment for Mr WP: thiazolidinediones after troglitazone.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20020101
Title: Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus.
Journal: Diabetes, obesity & metabolism 20020101
Title: Type 2 diabetes management: a comprehensive clinical review of oral medications.
Journal: Comprehensive therapy 20020101
Title: The mode of action of thiazolidinediones.
Journal: Diabetes/metabolism research and reviews 20020101
Title: Differentiating members of the thiazolidinedione class: a focus on efficacy.
Journal: Diabetes/metabolism research and reviews 20020101
Title: Differentiating members of the thiazolidinedione class: a focus on safety.
Journal: Diabetes/metabolism research and reviews 20020101
Title: Where thiazolidinediones will fit.
Journal: Diabetes/metabolism research and reviews 20020101
Title: Novel insulin sensitizers: pharmacogenomic aspects.
Journal: Pharmacogenomics 20020101
Title: Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes.
Journal: Diabetes/metabolism research and reviews 20020101
Title: PPAR(gamma) and glucose homeostasis.
Journal: Annual review of nutrition 20020101
Title: Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
Journal: Diabetes technology & therapeutics 20020101
Title: Metabolic and additional vascular effects of thiazolidinediones.
Journal: Drugs 20020101
Title: [Changes in carbohydrate metabolism in the HIV/AIDS patient].
Journal: Nutricion hospitalaria 20020101
Title: Glitazones: clinical effects and molecular mechanisms.
Journal: Annals of medicine 20020101
Title: Long-term efficacy of triple oral therapy for type 2 diabetes mellitus.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101
Title: Thiazolidinedione therapy in a patient with diabetes after cardiac transplantation.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101
Title: Oral combination therapy for type 2 diabetes.
Journal: Diabetes/metabolism research and reviews 20020101
Title: Oral bioavailability and pharmacokinetics of PAT-5A, a new insulin sensitizer in rats.
Journal: European journal of drug metabolism and pharmacokinetics 20020101
Title: Insulin-sensitizing agents--thiazolidinediones (glitazones).
Journal: Current medical research and opinion 20020101
Title: Differences in lipid profiles of patients given rosiglitazone followed by pioglitazone.
Journal: Current medical research and opinion 20020101
Title: Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20020101
Title: Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma.
Journal: The Journal of biological chemistry 20011221
Title: [Insulin sensitizer drugs, thiazolidinediones: current state and prospect].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: [A role of the PPAR gamma activation in insulin resistance].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: [Development of new antidiabetic drugs through the advanced knowledge of molecular biology in insulin signal transduction].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: [Clinical difference between thiazolidinediones and biguanides].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: [Evaluation of thiazolidinedione derivative drugs for safety].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: [Clinical usefulness of combination treatment with thiazolidinedione and insulin].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20011101
Title: PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Journal: International journal of cancer 20011101
Title: [Type 2 diabetes. Regulating insulin according to need].
Journal: MMW Fortschritte der Medizin 20011018
Title: Inhibition of monocyte chemoattractant protein-1 expression in cytokine-treated human lung epithelial cells by thiazolidinedione.
Journal: Chest 20011001
Title: Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors.
Journal: Prostaglandins, leukotrienes, and essential fatty acids 20011001
Title: A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes.
Journal: Biochimie 20011001
Title: Combination oral agent and insulin therapy for type 2 diabetes mellitus.
Journal: Current diabetes reports 20011001
Title: TNFalpha inhibits insulin's antiapoptotic signaling in vascular smooth muscle cells.
Journal: Biochemical and biophysical research communications 20010928
Title: Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
Journal: Biochemical and biophysical research communications 20010928
Title: Galectin-12, an Adipose-expressed Galectin-like Molecule Possessing Apoptosis-inducing Activity.
Journal: The Journal of biological chemistry 20010907
Title: Peroxisome proliferator-activated receptor-gamma-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta(12,14)-prostaglandin J(2).
Journal: The Journal of biological chemistry 20010907
Title: [News in oral antidiabetic therapy].
Journal: Vnitrni lekarstvi 20010901
Title: Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation.
Journal: Cancer research 20010815
Title: [The thiazolidinedione derivates: a new class of oral blood glucose lowering agents].
Journal: Nederlands tijdschrift voor geneeskunde 20010811
Title: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.
Journal: Nature medicine 20010801
Title: Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s).
Journal: The American journal of the medical sciences 20010801
Title: Pharmacological treatment of insulin resistance in obesity.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 20010801
Title: [Thiazolidinediones--a new class of oral antidiabetic drugs].
Journal: Orvosi hetilap 20010722
Title: Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones.
Journal: The Journal of biological chemistry 20010706
Title: A new era in type 2 diabetes mellitus treatment?
Journal: The American journal of medicine 20010701
Title: Insulin resistance induced in dairy steers by tumor necrosis factor alpha is partially reversed by 2,4-thiazolidinedione.
Journal: Domestic animal endocrinology 20010701
Title: Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.
Journal: European journal of pharmacology 20010629
Title: Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.
Journal: European journal of pharmacology 20010622
Title: Type 2 diabetes. How new insights, new drugs are changing clinical practice.
Journal: Geriatrics 20010601
Title: [Value of glitazones in therapy of type 2 diabetes: pro].
Journal: Deutsche medizinische Wochenschrift (1946) 20010518
Title: Troglitazone induces GLUT4 translocation in L6 myotubes.
Journal: Diabetes 20010501
Title: Induction of plasminogen activator inhibitor 1 gene expression in adipocytes by thiazolidinediones.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010501
Title: Oral agents in the management of type 2 diabetes mellitus.
Journal: American family physician 20010501
Title: [Current and future aspects of oral antidiabetic agents in type 2 diabetes].
Journal: Vnitrni lekarstvi 20010501
Title: New oxadiazolidinedione derivatives as potent and selective human beta3 agonists.
Journal: Bioorganic & medicinal chemistry letters 20010423
Title: Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.
Journal: The Journal of biological chemistry 20010420
Title: Using thiazolidinediones: rosiglitazone and pioglitazone in clinical practice.
Journal: The American journal of managed care 20010401
Title: [Glitazones. Profile of a new class of substances].
Journal: Der Internist 20010401
Title: Obesity and free fatty acids: double trouble.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 20010401
Title: [Study on 3D-QSAR of PPAR gamma agonists with thiazolidinedione and arylketo-acid moieties].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20010401
Title: 2,4-Thiazolidinediones as potent and selective human beta3 agonists.
Journal: Bioorganic & medicinal chemistry letters 20010326
Title: The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.
Journal: Molecular pharmacology 20010301
Title: Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats.
Journal: Diabetes 20010301
Title: Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione.
Journal: Pharmacotherapy 20010201
Title: [Significance of PPAR gamma (peroxisome proliferator-activated receptor gamma) in atherosclerosis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20010201
Title: PPAR gamma: an essential role in metabolic control.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 20010201
Title: The hormone resistin links obesity to diabetes.
Journal: Nature 20010118
Title: Thiazolidinediones (PPARgamma agonists) but not PPARalpha agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes.
Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010101
Title: Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes.
Journal: Metabolism: clinical and experimental 20010101
Title: Insulin resistance and its treatment by thiazolidinediones.
Journal: Recent progress in hormone research 20010101
Title: Interaction between peroxisome proliferator-activated receptor gamma and its agonists: docking study of oximes having 5-benzyl-2,4-thiazolidinedione.
Journal: Journal of molecular graphics & modelling 20010101
Title: Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
Journal: European journal of medicinal chemistry 20010101
Title: Hepatotoxicity with thiazolidinediones: is it a class effect?
Journal: Drug safety 20010101
Title: Structure toxicity relationships--how useful are they in predicting toxicities of new drugs?
Journal: Advances in experimental medicine and biology 20010101
Title: The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
Journal: Metabolism: clinical and experimental 20001201
Title: Enhancing effect of troglitazone on porcine adipocyte differentiation in primary culture: a comparison with dexamethasone.
Journal: Obesity research 20001201
Title: Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.
Journal: FEBS letters 20001027
Title: Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.
Journal: British journal of pharmacology 19991101
Title: L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
Journal: The Journal of biological chemistry 19990319
Title: 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures.
Journal: Endocrinology 19980501